TNF Pharmaceuticals Begins Trading Under New Nasdaq Stock Symbol TNFA Effective Before Market Open Today - StockTitan

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 61% of MyMD Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in MyMD Pharmaceuticals suggests that many traders are alarmed regarding MyMD Pharmaceuticals' prospects. The current market sentiment, together with MyMD Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use MyMD Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
TNF Pharmaceuticals Begins Trading Under New Nasdaq Stock Symbol TNFA Effective Before Market Open Today StockTitan

Read at news.google.com
Google News at Macroaxis
  

MyMD Pharmaceuticals Fundamental Analysis

We analyze MyMD Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

MyMD Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

MyMD Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MyMD Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

MyMD Pharmaceuticals Related Equities

UBXUnity Biotechnology   4.17   
0%
75.0%
NBYNovaBay Pharmaceuticals   3.85   
0%
69.0%
RXRXRecursion Pharmaceuticals   3.58   
0%
64.0%
GOVXGeoVax Labs   2.26   
0%
40.0%
DSGNDesign Therapeutics   2.25   
0%
40.0%
BOLTBolt Biotherapeutics   2.00   
0%
35.0%
KZRKezar Life   1.86   
0%
33.0%
NVCTNuvectis Pharma   1.53   
0%
27.0%
XBIOXenetic Biosciences   1.47   
0%
26.0%
REPLReplimune   1.30   
0%
23.0%
SRZNSurrozen   0.08   
0%
1.0%
AVIRAtea Pharmaceuticals   0.31   
5.0%
0%
LGNDLigand Pharmaceuticals   0.37   
6.0%
0%
KRONKronos Bio   1.04   
18.0%
0%
PASGPassage Bio   1.52   
27.0%
0%
LYELLyell Immunopharma   1.61   
28.0%
0%
ORICOric Pharmaceuticals   1.68   
30.0%
0%
GOSSGossamer Bio   2.33   
41.0%
0%
KROSKeros Therapeutics   2.39   
42.0%
0%
REVBRevelation Biosciences   3.23   
58.0%
0%
LRMRLarimar Therapeutics   4.55   
81.0%
0%
LYRALyra Therapeutics   5.56   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets